131 related articles for article (PubMed ID: 21217672)
1. NOX-4 is expressed in thickened pulmonary arteries in idiopathic pulmonary fibrosis.
Pache JC; Carnesecchi S; Deffert C; Donati Y; Herrmann FR; Barazzone-Argiroffo C; Krause KH
Nat Med; 2011 Jan; 17(1):31-2; author reply 32-3. PubMed ID: 21217672
[No Abstract] [Full Text] [Related]
2. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts.
Amara N; Goven D; Prost F; Muloway R; Crestani B; Boczkowski J
Thorax; 2010 Aug; 65(8):733-8. PubMed ID: 20685750
[TBL] [Abstract][Full Text] [Related]
3. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury.
Hecker L; Vittal R; Jones T; Jagirdar R; Luckhardt TR; Horowitz JC; Pennathur S; Martinez FJ; Thannickal VJ
Nat Med; 2009 Sep; 15(9):1077-81. PubMed ID: 19701206
[TBL] [Abstract][Full Text] [Related]
4. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
[TBL] [Abstract][Full Text] [Related]
5. miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2.
Fierro-Fernández M; Busnadiego Ó; Sandoval P; Espinosa-Díez C; Blanco-Ruiz E; Rodríguez M; Pian H; Ramos R; López-Cabrera M; García-Bermejo ML; Lamas S
EMBO Rep; 2015 Oct; 16(10):1358-77. PubMed ID: 26315535
[TBL] [Abstract][Full Text] [Related]
6. NADPH Oxidases and Aging Models of Lung Fibrosis.
Bernard K; Thannickal VJ
Methods Mol Biol; 2019; 1982():487-496. PubMed ID: 31172491
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidases: Pathophysiology and therapeutic potential in age-associated pulmonary fibrosis.
Kato K; Hecker L
Redox Biol; 2020 Jun; 33():101541. PubMed ID: 32360174
[TBL] [Abstract][Full Text] [Related]
8. Lung disease: resetting the redox balance in lung fibrosis.
Bray N
Nat Rev Drug Discov; 2014 Jun; 13(6):415. PubMed ID: 24833297
[No Abstract] [Full Text] [Related]
9. Putting the brakes on age-related idiopathic pulmonary fibrosis: can Nox4 inhibitors suppress IPF?
Turn CS; Lockey RF; Kolliputi N
Exp Gerontol; 2015 Mar; 63():81-2. PubMed ID: 25668226
[No Abstract] [Full Text] [Related]
10. Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets.
Liu YM; Nepali K; Liou JP
J Med Chem; 2017 Jan; 60(2):527-553. PubMed ID: 28122457
[TBL] [Abstract][Full Text] [Related]
11. NADPH oxidase-mediated induction of reactive oxygen species and extracellular matrix deposition by insulin-like growth factor binding protein-5.
Yasuoka H; Garrett SM; Nguyen XX; Artlett CM; Feghali-Bostwick CA
Am J Physiol Lung Cell Mol Physiol; 2019 Apr; 316(4):L644-L655. PubMed ID: 30810066
[TBL] [Abstract][Full Text] [Related]
12. Redox Imbalance in Idiopathic Pulmonary Fibrosis: A Role for Oxidant Cross-Talk Between NADPH Oxidase Enzymes and Mitochondria.
Veith C; Boots AW; Idris M; van Schooten FJ; van der Vliet A
Antioxid Redox Signal; 2019 Nov; 31(14):1092-1115. PubMed ID: 30793932
[No Abstract] [Full Text] [Related]
13. [Current progression in the biomarkers of idiopathic pulmonary fibrosis].
Wang XF; Zhang YW; Cai HR
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):841-3. PubMed ID: 24507397
[No Abstract] [Full Text] [Related]
14. Metformin attenuates lung fibrosis development via NOX4 suppression.
Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
[TBL] [Abstract][Full Text] [Related]
15. MMP28 in Idiopathic Pulmonary Fibrosis: Beyond the Extracellular Matrix.
Atamas SP
Am J Respir Cell Mol Biol; 2018 Jul; 59(1):5-6. PubMed ID: 29957054
[No Abstract] [Full Text] [Related]
16. Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis.
Tjin G; White ES; Faiz A; Sicard D; Tschumperlin DJ; Mahar A; Kable EPW; Burgess JK
Dis Model Mech; 2017 Nov; 10(11):1301-1312. PubMed ID: 29125826
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis.
Vukmirovic M; Herazo-Maya JD; Blackmon J; Skodric-Trifunovic V; Jovanovic D; Pavlovic S; Stojsic J; Zeljkovic V; Yan X; Homer R; Stefanovic B; Kaminski N
BMC Pulm Med; 2017 Jan; 17(1):15. PubMed ID: 28081703
[TBL] [Abstract][Full Text] [Related]
18. The Aging Lung and Idiopathic Pulmonary Fibrosis.
Gulati S; Thannickal VJ
Am J Med Sci; 2019 May; 357(5):384-389. PubMed ID: 31010465
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of siPTPN13 and siNOX4
Hou J; Ji Q; Ji J; Ju S; Xu C; Yong X; Xu X; Muddassir M; Chen X; Xie J; Han X
Theranostics; 2021; 11(7):3244-3261. PubMed ID: 33537085
[No Abstract] [Full Text] [Related]
20. Lysyl Oxidase-Like 1 Protein Deficiency Protects Mice from Adenoviral Transforming Growth Factor-β1-induced Pulmonary Fibrosis.
Bellaye PS; Shimbori C; Upagupta C; Sato S; Shi W; Gauldie J; Ask K; Kolb M
Am J Respir Cell Mol Biol; 2018 Apr; 58(4):461-470. PubMed ID: 29115860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
